Tag Archives for U.S. Department of Health and Human Services

Rhode Island PR Campaign to Reduce Older Adult Overdoses

Published in RINewsToday on February 16, 2026

Four months ago, the State of Rhode Island joined an estimated 5,000 community coalitions across the nation and U.S. territories to participate in the 2025 National Substance Use and Misuse Prevention Month. The Substance Abuse and Mental Health Services Administration (SAMHSA), a branch of the U.S. Department of Health and Human Services, organizes this annual federal initiative to highlight the importance of early intervention and community-based prevention strategies.

During November, the State launched its 2025 public awareness campaign titled No Matter Why You Use, aimed at preventing overdose deaths among adults ages 45 to 64 and older. This demographic group faces unique and often complex health risks that increase the likelihood of fatal overdose, making the campaign an important component of the Ocean State’s comprehensive strategy to reduce overdose deaths and improve lives.

The initiative focuses on aging adults who use substances, providing education and resources to help them feel more connected. “It’s also about eliminating stigma and amplifying the voices of those with lived experience,” said Cathy Schultz, Director of the Governor’s Overdose Task Force, in the statement announcing the program.

The statement also included comments from Linda Mahoney of the state’s Behavioral Healthcare, Developmental Disabilities & Hospitals (BHDDH), who emphasized the campaign’s creative approach: “The approach we’ve used is designed to elicit a reaction of ‘this is my struggle,’ ‘that could be my friend,’ or ‘that could be my parent.’ The average person doesn’t typically connect substance use with older adults, but that’s part of the issue we face. If we can raise greater awareness of this reality, we can make meaningful strides in prevention, recovery, and eliminating stigma.”

Maria Cimini, Director of the Rhode Island Office of Healthy Aging, highlighting the state’s responsibility as its older adult population grows. “We must see the full humanity of older adults and confront the issues that too often remain hidden. Substance use is not a moral failing—it’s a public health challenge. By meeting people where they are, connecting them to care, and breaking the silence around stigma, we can build stronger, healthier communities for everyone.”

Data Reveals Rising Overdose Risks for Older Rhode Islanders

According to Joseph Wendelken, RI Dept. of Health’s Public Information Officer, national rates of accidental and undetermined fatal overdoses declined from 2023 to 2024 among adults ages 55–64 (from 51.8 to 41.1 per 100,000) and those 65 and older (from 13.4 to 12.5 per 100,000).

Wendelken noted that Rhode Island, however, experienced different trends. During the same period, the overdose rate increased among adults ages 55–64 (from 51.6 to 63.5 per 100,000) but decreased among those 65 and older (from 15.6 to 12.4 per 100,000).

While much of the national conversation about overdose focuses on younger populations, research shows that middle-aged and older Rhode Islanders often struggle with co-existing physical and mental health conditions, chronic pain, isolation, stigma, and limited access to care — factors that can contribute to rising rates of substance use and overdose, says RIDOH.

Among the key statistics driving the public relations campaign are findings from Rhode Island’s 2024 fatal overdose data. Individuals ages 45 to 64 are experiencing accidental drug overdose deaths at significantly higher rates than the statewide average.

Compared to previous years, the Health Dept. says that the rate of accidental drug overdose deaths continues to rise among individuals ages 55 to 64 in Rhode Island. Most overdose deaths in this age group (87%) occurred in private settings, such as homes.

Stimulants — including cocaine, crack cocaine, methamphetamine, and amphetamines — contributed to 65% of fatal overdoses in this age group, reflecting a growing public health concern beyond opioid-related deaths. Fentanyl was involved in more than half (51%) of fatal overdoses, underscoring its continued role as a primary driver of overdose deaths. A combination of fentanyl and cocaine contributed to 34% of overdoses in this population.

The greatest proportion of overdoses in this age group occurred among males (69%) and non-Hispanic white individuals (74%).

A Statewide Strategy to Prevent Overdose and Save Lives

“The No Matter Why You Use campaign raises awareness of substance use and overdose risks among middle-aged and older adults, provides clear prevention information, and directs Rhode Islanders to PreventOverdoseRI.org for treatment and recovery resources,” said Wendelken. Educational materials have been distributed to hundreds of community partners, including senior centers, healthcare providers, libraries, senior housing sites, and recovery community centers.

The No Matter Why You Use campaign is being led in partnership by the Rhode Island Executive Office of Health and Human Services (EOHHS), BHDDH, OHA, and RIDOH. .

This data-driven campaign supports Gov. Dan McKee’s Overdose Task Force “Roadmap,” which is built on four pillars: strengthening comprehensive prevention; expanding harm reduction and rescue efforts; increasing engagement in treatment; and supporting recovery,” Wendelken explained.

The state initiative is guided by cross-cutting strategies designed to promote an equitable response to the overdose epidemic. These strategies include embedding racial equity across all pillars; strengthening governance and community engagement; expanding data capacity and surveillance; and addressing social determinants of health throughout each pillar.

According to Wendelken, this evidence-informed approach aligns with Rhode Island’s broader overdose prevention strategy and ongoing efforts to save lives.

The state partnered with RDW Group on the No Matter Why You Use campaign. The initiative is based on formative research that included in-depth interviews with subject-matter experts and individuals with lived experience — including people in recovery, counselors, social workers, community advocates, and physicians. These authentic voices helped shape the campaign’s messaging, which emphasizes the impact of stigma, hopelessness, and emotional distress as common triggers for substance use among aging adults who may feel isolated or disconnected.

The campaign’s powerful, portrait-style imagery and first-person messaging acknowledge that people use substances for complex reasons — including isolation, pain, trauma, anxiety, and depression — while centering compassion at its core: No matter why you use, your life matters. Hope and help are here, adds RIDOH.

You can find stories of local Rhode Islanders sharing their powerful recovery stories on the RIDOH (go to https://pori.soapboxx.com).

Designed to help individuals feel safe, seen, and supported, the campaign connects Rhode Islanders to local treatment, recovery, and harm reduction resources at PreventOverdoseRI.org. Its media strategy uses data-driven insights from fatal overdose heat maps to target placements for aging adult audiences. Outreach includes digital advertising on social media, website and app display ads, local and streaming radio spots, and advertisements on gasoline pump televisions.

RIDOH notes that The No Matter Why You Use campaign also includes grassroots outreach to more than 250 organizations statewide. Its launch is part of a comprehensive and ongoing effort by Rhode Island to address substance use and related public health crises.

From Crisis to Recovery

The state’s new No Matter Why You Use campaign, aimed at reducing overdose deaths and addressing stigma among older adults, marks an important first step in combating substance use disorder, says Diane Dufresne, Director of the Pawtucket Prevention Coalition. The coalition is a community organization dedicated to addressing social issues such as substance use, poverty, and homelessness.

Dufresne emphasizes the importance of using precise, nonjudgmental language like “substance use disorder” to shape public perception and support recovery.

“The state’s campaign sloganis powerful because it centers compassion over judgment and makes one thing clear: every life is worth saving,” says Dufresne, who holds a degree in counseling and has been a certified prevention specialist for five years. She also brings more than 40 years of experience as a registered nurse, this extensive clinical background strengthening  her work in substance use prevention and advocacy.

Drawing on her frontline experience, Dufresne agrees with the state’s assessment that substance use and overdose rates are rising among adults age 45 and older. She attributes this trend in part to limited harm-reduction education available to this generation.

“Many older adults developed addictions through legitimate opioid prescriptions and now face complex health challenges, including dangerous interactions with medications prescribed for coexisting conditions,” she explains.

Dufresne notes that shame and stigma are primary drivers of isolation among older adults, increasing the risk of fatal overdoses. “Older adults are more likely to use substances alone in private settings. “Younger people have received more harm-reduction education and better understand the risks of using alone,” she says.

Dufresne also highlights significant barriers to treatment, including transportation challenges, insurance limitations, technology gaps, and reduced mobility. Addressing these obstacles, she says, will require increased state funding and more targeted outreach efforts.

“Increased funding is necessary for community organizations to expand anti-stigma education, provide training opportunities, and connect older adults with treatment and recovery services,” Dufresne says.

The No Matter Why You Use campaign acknowledges the unique challenges facing this demographic, including limited exposure to modern harm-reduction practices, a higher likelihood of addiction stemming from prescribed opioids, and increased social isolation.

Dufresne advocates pairing Narcan distribution with anti-stigma education and recommends practical strategies to reach isolated seniors.

“Effective outreach should include combined Narcan and anti-stigma training in senior housing and community centers, along with door hangers that provide service information for individuals in private residences,” she says.

Above all, Dufresne stresses that saving lives must remain the priority.

“The act of saving a life should never be influenced by judgments about a person’s history of addiction or previous overdoses,” she says.

Federal Court denies attempt to stop Medicare drug negotiation program

Published in RINewsToday on November 6, 2023

Over two months ago, as supporters of President Biden’s Inflation Reduction Act (IRA) celebrated the one-year anniversary of the passage of the historic legislation, the U.S. Chamber of Commerce, Pharmaceutical Research and Manufacturers of America (PhRMA), along with drugmakers filed multiple lawsuits to block the IRA’s drug price negotiation provisions.  The drug price negotiation program, created by IRA, allows Medicare to use its bargaining power to negotiate the prices of ten prescription drugs for the first time.

The multiple-filed legal suits came weeks before Sept. 1 when the for Centers Medicare & Medicaid Services (CMS) was scheduled to publish a list of the first 10 drugs that would be subjected to negotiations.  These lawsuits argued that the federal price negotiation program was unconstitutional because it violated the First and Fifth Amendments of the U.S. Constitution, as well as the separation of powers clause, by giving the U.S. Department of Health and Human Services (HHS) discretion over a maximum fair price for any given drug selected for negotiation.  These lawsuits also charge that CMS price controls would force drug makers to pull back on developing new drugs, jeopardizing medical breakthroughs for individuals with life-threatening and chronic illnesses. 

Among the nine lawsuits scheduled to go to trial, one was a motion filed on July 12, 2023 by the Chamber and several of its affiliates in Ohio. This motion requested the court to issue a preliminary injunction to halt the Medicare drug negotiation program from implementation. The ruling came before the Oct. 1, 2023 deadline requiring drugmakers whose pharmaceuticals were selected for negotiations to either sign agreements to participate or to face stiff penalties.  

The U.S. Department of Justice opposed the Chamber’s motion, filing a motion to dismiss its case.  On Sept. 15, 2023, the court held oral arguments giving the  Chamber and the DOJ an opportunity to present their legal arguments in greater detail.  

Overcoming a Major Legal Hurdle 

On Friday, September 29, 2023, U.S. District Judge Michael J. Newman for Southern District of Ohio, denied the Chambers request to block implementation of the newly established Medicare drug price negotiation program before the drug price negotiation talks began.  The ruling called on the Chamber to file an amended complaint by Oct. 13, 2023. DOJ would then have until Oct. 27, 2023 to renew its motion to dismiss.

According to Spencer Kimball of CNBC, legal experts say the pharmaceutical industry hopes to see conflicting rules from lawsuits filed in other federal appellate courts to bring this issue to the Supreme Court for final resolution. 

The Willimantic, Connecticut-based Center for Medicare Advocacy (CMA), a nonprofit group pushing for comprehensive Medicare coverage, health equity and quality of health care for seniors and people with disabilities, is encouraged by Judge Newman’s ruling, which assessed the drug manufacturer’s claims “to be weak in the face of clearly established laws.”

According to CMA, the 28-page court order found that the Chamber and other plaintiffs had demonstrated neither likelihood of success on the merits, nor irreparable harm, which are required for a preliminary injunction.  CMS noted that this case cited “clear” law that “participation in Medicare, no matter how vital it may be to a business model, is a completely voluntary choice.” The court also found that the price established by negotiations cannot be considered ‘confiscatory,’ as the Chamber charges or “a violation of due process, because drug manufacturers can opt out of Medicare entirely.”

Newman’s ruling noted that drugmakers are not compelled to sell drugs at the prices established by the Medicare program and that any economic harm, when the negotiated drug prices take effect in 2026, was too speculative to warrant immediate relief, reported CMS.  However, the court did deny the government’s motion to dismiss the lawsuit entirely, saying that more information on whether the plaintiffs have standing to sue would be beneficial and therefore the judge is allowing for limited discovery to clarify issues related to legal standing, after which the government may renew its motion to dismiss, noted the Medicare advocacy group.

With this ruling, Medicare may move forward with its implementation of its drug negotiation program as this case and others continue to proceed. 

Giving their two cents…

At press time, the Chamber did not respond to a request for comment about the court’s ruling.  But health care and aging advocacy groups issued statements expressing their thoughts about the impact of Newman’s ruling. 

“This is the first major blow to Big Pharma in its legal battles to block the drug price negotiation provisions under the Inflation Reduction Act, says Peter Maybarduk, Public Citizen’s director of the Access to Medicines program.

“The Chamber’s lawsuit lacks merit; the court made the right decision not to grant the injunction, which would have caused needless patient suffering and treatment rationing, notes Maybarduk, calling on drugmakers “to drop their lawsuits and drop their prices.”

“Now, drug companies should agree to participate in the negotiation program in good faith. The program is an important first step in ending the exorbitant prices charged to Medicare enrollees,” adds Maybarduk.

Frederick Isasi, Executive Director of Families USA, happily noted that the Medicare drug negotiation program continues, calling the ruling “a big win for seniors and their ability to purchase life-saving medications. The ability to afford medication is a matter of life and death for millions of older adults. That’s why we are fighting this David and Goliath battle – people deserve to pay a fair price for their drugs and Medicare price negotiation is a critical piece of this puzzle. And let’s not forget each drug subject to fair price negotiation is an old drug that millions of people need and doesn’t have competition,” he notes.

“It never ceases to amaze us that – on one hand – Big Pharma can cry poverty by saying that drug negotiations will hurt their bottom line, while recent earnings reports show they are raking in money hand over fist.  We are glad Judge Michael J. Newman, a Trump appointee in Ohio’s Southern District, saw through this hypocrisy by affirming the Biden administration’s power to begin negotiating the prices of 10 medications with drugmakers,” says Dan Adcock, Director of Government Relations and Policy, of the Washington, DC-based National Committee to Preserve Social Security and Medicare. (NCPSSM).

According to NCPSSM, Drug makers made a whopping $493 billion in revenue from ten drugs that are now subject to price negotiations between CMS and the manufacturer, which have accounted for more than $170 billion in gross Medicare spending, according to a report from the nonprofit, Protect Our Care.

“The court’s decision to allow Medicare drug price negotiations to move forward is welcome news, says William Alvarado Rivera, Senior Vice President for Litigation at AARP Foundation. “Pausing Medicare negotiations would have risked billions of dollars in savings for taxpayers – and countless lives. It is unconscionable that Americans face such high prescription drug costs that many people skip taking medication altogether or must ration it,” he said.

“We’re prepared to fight for as long as necessary to ensure big drug companies can’t charge excessive prices at the expense of patients’ health, says Rivera, noting that the new Medicare negotiation law would bring financial and medical relief to millions of older Americans and their families, and put drugs that treat life-threatening and chronic conditions, from cancer to heart disease, within their reach. Rivera says, “It must not be derailed.” 

Congress has put the breaks to the spiraling costs of pharmaceuticals by giving Medicare the authority to negotiate the price of popular drugs with drug makers.  America’s seniors will continue to suffer financial  hardships and many might even lose their lives by not choosing not to take their costly medications if courts rule in favor of drug companies.  Time will tell.   

U.S. Judge Michael J. Newman ruling denying the U.S. Chamber of Commerce’s request for a preliminary injunction, go to https://www.bloomberglaw.com/public/desktop/document/DaytonAreaChamberofCommerceetalvBecerraetalDocketNo323cv00156SDOh/5?doc_id=X3U600KOGG69QHQBPEU24OS1JMO

A listing of drugmaker revenues of the first ten negotiated drugs, go to https://www.protectourcare.org/by-the-numbers-the-ten-costly-drugs-that-are-now-eligible-to-have-lower-prices-negotiated-by-medicare/

The Village helps grandparent/kinship caregivers in need

Published in RINewsToday on September 18, 2023

When we dream about our retirement years, these dreams most likely don’t include images of diapers, children’s tantrums, and school buses. However, for some grandparents and other kinship caregivers, their later years include these images, as they become primary caregivers for their grandchildren/kin children.

Nationally, more than 2.5 million children are being raised in kinship families which includes grandparents, other extended family members, or anyone with an existing relationship with the child or family. When these children cannot be with their parents, the next best thing is being placed with kin.

There are many benefits to staying with kin rather than being placed into the state’s foster care system. These can include experiencing less trauma; increased stability, higher rates of permanency; better behavioral and mental health outcomes; more feelings of belonging and being accepted, increased likelihood of living with or staying connected to their siblings, and a greater sense of cultural identity and connections to family.  

Additionally, kinship caregivers save the U.S economy approximately $ 6 billion dollars per year by keeping children out of formal foster care. Across the nation, there is a growing recognition of the importance and value of kinship caregivers. However, all of this comes at a physical, mental and financial cost to the kinship

The challenges of being a kinship caregiver

A new research study, Caregiver Profile: A Closer Look at Grandparents Caring for Grandchildren, by the National Rehabilitation Research and Training Center on Family Support (NCFS) at the University of Pittsburg, grandparent caregivers are experiencing a litany of adverse effects causing them to become a particularly vulnerable group. Grandparents are facing a higher rate of disability, lower employment, and a greater likelihood of poverty, says the study’s findings. One quarter of grandparents raising grandchildren live below the poverty line.

“Many challenges exist for grandparent and kin caregivers of children when it comes to navigating the legal and custody landscape while supporting their own needs, from physical and mental health to financial and employment security. We think this data [detailed in the 16 page report released in Sept. 2023] showcases the need to move forward on the recommendations developed by the Advisory Council to Support Grandparents Raising Grandchildren (SGRG) and the Recognize, Assist, Include, Support, and Engage (RAISE) Act Family, Caregiving Advisory Council that can help to support grandparent and kin caregivers,” said Meredith Hughes, JD, MPH, Senior Policy Analyst at University of Pittsburgh Health Policy Institute and Assistant Professor in the School of Public Health.”

 It is important to provide supportive services for grandparents raising grandchildren as many of these caregivers lack the necessary resources to fully support the children in their care. Support in areas such as kinship navigator programs that provide a single-entry point for learning about housing, health services, and financial and legal assistance, along with improved household resources and access to mental health services are needed. Rhode Island has a kinship navigator program for families involved with the department, but currently one does not exist for those who are not involved.  For every family involved with the Rhode Island Department of Children, Youth & Families, (DCYF), there are 5 who are not.

Grandparenting in the Ocean State

cording to the U.S. Census bureau, over 13,968 children are living with and being raised by their grandparents in Rhode Island, who make up the largest percentage of relative caregivers. Some kin families are involved with the child welfare system when children have to be removed from their home on an emergency basis. Rhode Island is one of the leading states in the nation in finding and placing children with kin. The state’s long-held philosophy is that children do better by living with kin. Of all the children in the state’s foster care system, around 70% are placed with kin.

For families involved with the DCYF, (known as “formal” kin caregivers) while it can be a distressing experience, they do gain access to needed resources and services, as well as receive monthly stipends and other supports to care for the children. For families who have private arrangements and are not involved with DCYF (“informal” caregivers), finding those resources and services can be challenging. Many if not most of kinship families are not involved with the child welfare system and have no idea that there are any resources. Finding and supporting those families has become one mission of the Cranston-based The Village for RI Foster and Adoptive Families (The Village) and the Warwick-based Hispanic Foster and Adoptive Parents Organization of Rhode Island (The Heart Tree).

The Village, established in 2016 by a group of five foster and adoptive families, provides peer support to all RI foster, adoptive and kin families. The Village provides support through peer mentoring, peer-led support groups and family events, as well as running a “Closet” where families both donate and receive material things such as clothing, toys, diapers etc. The Heart Tree, a sister organization, also provides those same supports in a culturally appropriate manner to our Spanish speaking families. The Heart Tree was established in 2021 to meet the unique needs of Spanish speaking foster, adoptive and kin families.

Sixty-three-year-old Laurie Tapozada is a kinship caregiver who sees the value of the assistance provided by the The Village in raising her 8-year-old grandson. “When it first happened and I was suddenly raising a baby at age 55, I didn’t know one single other family like mine, she said.

“My life was turned on its head, I was struggling to manage my hectic work schedule with a baby and dealing with all sorts of messy and painful family dynamics that come with being a kinship caregiver,” says Tapozada.

According to Tapozada, she had to re-educate herself as to how to safely raise a baby without getting support from family and friends who thought she was “crazy” for taking this on. It was overwhelming and distressing until she received a call from a friend who suggested that she “call the Village and they will understand.”  From that point Tapozada has become actively involved in the kinship community and network, “It been a life changer for me,” she says.

Although Rhode Island is recognized as a leader in ensuring that children removed from homes are placed with kin, increasing support for kin families is a pressing need.  In 2022, the Rhode Island Office of Healthy Aging awarded a grant (through funding from the U.S. Administration for Community Living overseen by the U.S. Department of Health and Human Services) to the Village and the Heart Tree, to identify informal kin families and help connect them to existing resources, and to the growing kinship caregiver community. 

RIOHA’s grant also funded a multi-faceted effort, in person and online activities, and incorporating traditional print, broadcast, digital and social media communication and training.  Throughout the year, exhibit tables were placed at family events, informational meetings and festivals to get the word out about available resource for kindship caregivers. This grant also created a statewide website where these individuals could go and learn more about resources, as well as find out what is happening in the kin community. This website is www.kinshipcommunityconnections.org.

Project Director Shannon Dos Santos, of the Village, sees the value and positive impact of this grant on Rhode Island’s kinship caregiver families. “I have seen the joy on the faces of many Kinship Caregivers aged 55 and over and their families over the last fifteen months as a result of this grant,” she says, noting that reaching out to this population and getting them to engage has been a challenge. “But when they do – it is beautiful to watch.”

According to Dos Santos, many just feel isolated, overwhelmed and alone. “This grant has allowed us to focus on community outreach and engagement as well as provided us with opportunities to enhance what we at the Village do so well – peer support and family activities!  “It has been a blessing to watch these families come together at these events, form relationships with others in  similar situations and feel safe sharing their experiences,” she says.  

The Village’s Chairman of the Board, Sue Babin, who is also full-time employee and a kinship caregiver, too, added, “This exciting grant initiative has provided The Village with an opportunity to continue to do what we do best… peer outreach and support from people with lived experiences.” And, while RI OHA’s grant ends this month, additional funding will extend the program for 12 months, she says.

For info about The Village for RI Foster & Adoptive Families (The Village), go to https://www.rivillage.org/. Or call (401) 481-5483.

For info about Hispanic Foster and Adoptive Parents Organization of Rhode Island (The Heart Tree), go to https://sites.google.com/view/thehearttree/homeinicio?authuser=1.  Or Call (401) 306-9652.

For info about Kinship Community Connections, go to https://kinshipcommunityconnections.org/

WPRI 12’ s Rhode Island Video on Foster Care Month, go to https://www.youtube.com/watch?v=AhI206EXBfQ.

For a copy of the recently released research study, Caregiver Profile: A Closer Look at Grandparents Caring for Grandchildren, by NCFS at the University of Pittsburg, go to

https://www.caregiving.pitt.edu/caregiver-profile-closer-look-grandparents-caring-grandchildren